Question 1

What does Heptares Therapeutics do?

Accepted Answer

Heptares Therapeutics develops novel, small-molecule drugs for G-protein-coupled receptors (GPCRs).

Question 2

In what sectors does Heptares Therapeutics operate?

Accepted Answer

Heptares Therapeutics operates in Biotechnology, Pharmaceutical, Therapeutics.

Question 3

How many companies has Heptares Therapeutics acquired?

Accepted Answer

Heptares Therapeutics has made 2 acquisitions between 2014-2016, with a total disclosed deal value of $11.8M.

Question 4

What companies are owned by Heptares Therapeutics?

Accepted Answer

Companies acquired by Heptares Therapeutics include G7 Therapeutics, JITSUBO.

Question 5

What are Heptares Therapeutics's major acquisitions?

Accepted Answer

Heptares Therapeutics's largest acquisitions include G7 Therapeutics ($11.8M, 2016).

Question 6

What is Heptares Therapeutics's largest acquisition?

Accepted Answer

Heptares Therapeutics's largest disclosed acquisition is G7 Therapeutics for $11.8M (2016).

Question 7

What was Heptares Therapeutics's first acquisition?

Accepted Answer

Heptares Therapeutics's first recorded acquisition was JITSUBO in 2014.

Question 8

What was Heptares Therapeutics's most recent acquisition?

Accepted Answer

Heptares Therapeutics's most recent acquisition is G7 Therapeutics, announced November 2016 for $11.8M.

Question 9

What is the average deal size for Heptares Therapeutics acquisitions?

Accepted Answer

The average disclosed deal size for Heptares Therapeutics acquisitions is $11.8M.

Question 10

What is the median deal size for Heptares Therapeutics acquisitions?

Accepted Answer

The median disclosed deal size for Heptares Therapeutics acquisitions is $11.8M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has Heptares Therapeutics spent on acquisitions?

Accepted Answer

Heptares Therapeutics has spent at least $11.8M across its disclosed acquisitions (of 2 total deals; some prices are undisclosed).

Question 12

Which sector has Heptares Therapeutics spent the most on?

Accepted Answer

Heptares Therapeutics has committed the most disclosed capital to Pharmaceutical companies — about $11.8M across its deals in that sector.

Question 13

What sectors does Heptares Therapeutics usually acquire in?

Accepted Answer

Heptares Therapeutics most frequently acquires companies in Pharmaceutical, Chemical, Embedded Systems.

Question 14

In which sector has Heptares Therapeutics made the most acquisitions?

Accepted Answer

Heptares Therapeutics has made the most acquisitions in the Pharmaceutical sector.

Question 15

In which year did Heptares Therapeutics make the most acquisitions?

Accepted Answer

Heptares Therapeutics made the most acquisitions in 2016, with 1 deal.

Datasets

Top Companies

Top Industries

Years (1990-2026)

Heptares Therapeutics

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by Heptares Therapeutics

Key People at Heptares Therapeutics

Explore 200,000+ acquisitions — free

Recent News related to Heptares Therapeutics

FAQs about Heptares Therapeutics

People who checked this page also checked these